Israel says signed MOU with NRX Pharmaceuticals for COVID vaccine trials

Reuters |
Published: 07.12.21, 18:58
Israel has signed a memorandum of understanding with NRX Pharmaceuticals to complete trials and commercialize the Israeli-developed COVID-19 vaccine BriLife, the Defense Ministry said on Monday.
The vaccine was developed by the Israel Institute for Biological Research, which is overseen by the Defense Ministry.